Lexicon Pharmaceuticals LXRX Accrued taxes and other expenses
Accrued taxes and other expenses at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrentAndNoncurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's accrued taxes and other expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's accrued taxes and other expenses?
- Lexicon Pharmaceuticals (LXRX) reported accrued taxes and other expenses of $6.9M in Q1 2026.
- How has Lexicon Pharmaceuticals's accrued taxes and other expenses changed year-over-year?
- Lexicon Pharmaceuticals's accrued taxes and other expenses decreased by 46.7% year-over-year, from $12.95M to $6.9M.
- What is the long-term trend for Lexicon Pharmaceuticals's accrued taxes and other expenses?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's accrued taxes and other expenses has grown at a -15.0% compound annual growth rate (CAGR), from $29.69M to $13.19M.